- Previous Close
11.23 - Open
11.24 - Bid 11.15 x 3800
- Ask 11.18 x 1700
- Day's Range
11.12 - 11.39 - 52 Week Range
10.69 - 31.32 - Volume
11,221,523 - Avg. Volume
18,080,234 - Market Cap (intraday)
9.634B - Beta (5Y Monthly) 0.70
- PE Ratio (TTM)
-- - EPS (TTM)
-6.74 - Earnings Date Oct 10, 2024 - Oct 14, 2024
- Forward Dividend & Yield 1.00 (8.90%)
- Ex-Dividend Date Aug 21, 2024
- 1y Target Est
12.79
Walgreens Boots Alliance, Inc. operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise. The International segment offers sale of prescription drugs and health and wellness, beauty, personal care, and other consumer products outside the United States; and operates pharmacy-led health and beauty retail businesses under the Boots brand stores in the United Kingdom, the Republic of Ireland, and Thailand, as well as the Benavides brand in Mexico and the Ahumada brand in Chile. The U.S. Healthcare segment provides VillageMD, a national provider of value-based care with primary, multi-specialty, and urgent care providers serving patients in traditional clinic settings, in patients' homes and online appointments; Shields, a specialty pharmacy integrator and accelerator for hospitals; and CareCentrix, a participant in the post-acute and home care management sectors. Walgreens Boots Alliance, Inc. was founded in 1909 and is headquartered in Deerfield, Illinois.
www.walgreensbootsalliance.com206,000
Full Time Employees
August 31
Fiscal Year Ends
Sector
Industry
Recent News: WBA
View More
Performance Overview: WBA
Trailing total returns as of 7/24/2024, which may include dividends or other distributions. Benchmark is
.YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: WBA
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: WBA
View MoreValuation Measures
Market Cap
9.69B
Enterprise Value
41.67B
Trailing P/E
--
Forward P/E
5.25
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.07
Price/Book (mrq)
0.71
Enterprise Value/Revenue
0.29
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-3.99%
Return on Assets (ttm)
1.30%
Return on Equity (ttm)
-55.97%
Revenue (ttm)
145.53B
Net Income Avi to Common (ttm)
-5.81B
Diluted EPS (ttm)
-6.74
Balance Sheet and Cash Flow
Total Cash (mrq)
711M
Total Debt/Equity (mrq)
218.17%
Levered Free Cash Flow (ttm)
2.17B
Research Analysis: WBA
View MoreCompany Insights: WBA
WBA does not have Company Insights
Research Reports: WBA
View MoreWalgreens Earnings: Disappointing Results on Tough Retail Environment Muddying Near-Term Recovery
Walgreens Boots Alliance is one of the largest retail pharmacy chains in the US, with over 8,500 locations. Nearly three quarters of Americans live within five miles of a Walgreens location. Roughly two thirds of revenue is generated from prescription drug sales; Walgreens makes up 20% of total prescription revenue in the US. Walgreens also generates sales from retail products (general wellness consumables and its own branded merchandise), European drug wholesale, and healthcare. With more locations incorporating additional services like Health Corner and Village Medical, Walgreens creates an omnichannel experience for patients and positions itself as a one-stop healthcare provider.
RatingPrice TargetWalgreens Earnings: Disappointing Results on Tough Retail Environment Muddying Near-Term Recovery
Walgreens Boots Alliance is one of the largest retail pharmacy chains in the US, with over 8,500 locations. Nearly three quarters of Americans live within five miles of a Walgreens location. Roughly two thirds of revenue is generated from prescription drug sales; Walgreens makes up 20% of total prescription revenue in the US. Walgreens also generates sales from retail products (general wellness consumables and its own branded merchandise), European drug wholesale, and healthcare. With more locations incorporating additional services like Health Corner and Village Medical, Walgreens creates an omnichannel experience for patients and positions itself as a one-stop healthcare provider.
RatingPrice TargetMid Cap U.S. Pick List June 2024
This pick list highlights constituents of the Morningstar US Mid Cap Index that we believe offer investors the best risk-adjusted return prospects. The market capitalization range for U.S. mid-caps typically falls between $1 billion and $8 billion and represents 20% of the total capitalization of the U.S. equity market.
Reducing FY24 and FY25 estimates
Walgreens Boots Alliance Inc. based in Deerfield, Illinois, is a holding company created in December 2014 when Walgreen completed its purchase of privately held Alliance Boots. The company generated $139 billion in FY23 sales. After divesting its healthcare distribution business WBA has presence in more than 9 countries. About 85% of revenue is from the United States. The company has over 14,000 stores under the Walgreen, Duane Reade and Boots names. WBA owns about 16% of Cencora. WBA's fiscal year ends on August 31. The company has reclassified its operations again. The new organization has a United States Retail Pharmacy unit, an International unit, and a U.S. Healthcare segment, which includes recent investments in VillageMD, CareCentrix and Shields Health Solutions.
RatingPrice Target